Repurposing the dual orexin receptor antagonist suvorexant for the treatment of opioid use disorder: why sleep on this any longer?
Morgan H JamesJennifer E FragaleR Nisha AuroraNina A CoopermanDaniel D LanglebenGary Aston-JonesPublished in: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology (2020)